sempera liquid 10 mg/ml
janssen-cilag gmbh (8009839) - itraconazol - lösung zum einnehmen - itraconazol (23401) 10 milligramm
yescarta
kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastische mittel - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.
mysoline - tabletten
sanova pharma gmbh - primidon - primidon
sporanox 100 mg kapseln
janssen-cilag pharma gmbh - itraconazol - itraconazol
sporanox derm 100 mg kapseln
janssen-cilag pharma gmbh - itraconazol - itraconazol
sporanox 10 mg/ml lösung zum einnehmen
janssen-cilag pharma gmbh - itraconazol - itraconazol
itraconazol stada 100 mg kapseln
stada arzneimittel gmbh - itraconazol - itraconazol
itraconazol laboratorios liconsa 100 mg hartkapseln
laboratorios liconsa - itraconazol - itraconazol
itraderm 100 mg - hartkapseln
dermapharm gmbh - itraconazol - triazole derivatives
itraconazol stada 100 mg hartkapseln
stadapharm, gesellschaft mit beschränkter haftung (3364435) - itraconazol - hartkapsel - teil 1 - hartkapsel; itraconazol (23401) 100 milligramm